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ABSTRACT The structural features of volatile anesthetic binding sites on proteins are being examined with the use of a
defined model system consisting of a four--helix bundle scaffold with a hydrophobic core. Previous work has suggested that
introducing a cavity into the hydrophobic core improves anesthetic binding affinity. The more polarizable methionine side
chain was substituted for a leucine, in an attempt to enhance the dispersion forces between the ligand and the protein. The
resulting bundle variant has an improved affinity (Kd  0.20  0.01 mM) for halothane binding, compared with the
leucine-containing bundle (Kd 0.69 0.06 mM). Photoaffinity labeling with
14C-halothane reveals preferential labeling of the
W15 residue in both peptides, supporting the view that fluorescence quenching by bound anesthetic reports both the binding
energetics and the location of the ligand in the hydrophobic core. The rates of amide hydrogen exchange were similar for the
two bundles, suggesting that differences in binding affinity were not due to changes in protein stability. Binding of halothane
to both four--helix bundle proteins stabilized the native folded conformations. Molecular dynamics simulations of the
bundles illustrate the existence of the hydrophobic core, containing both W15 residues. These results suggest that in addition
to packing defects, enhanced dispersion forces may be important in providing higher affinity anesthetic binding sites.
Alternatively, the effect of the methionine substitution on halothane binding energetics may reflect either improved access to
the binding site or allosteric optimization of the dimensions of the binding pocket. Finally, preferential stabilization of folded
protein conformations may represent a fundamental mechanism of inhaled anesthetic action.
INTRODUCTION
The mechanism of action of inhaled general anesthetics
remains poorly understood (Franks and Lieb, 1994; Ecken-
hoff and Johansson, 1997). This situation results in part
from the fact that the in vivo targets for these clinical agents
are unknown, although membrane proteins that function as
ion channels and/or neurotransmitter receptors in the central
nervous system are currently in favor (Franks and Lieb,
1994; Harris et al., 1995). In support of this view are the
studies demonstrating that the activity of both ligand-gated
(Mihic et al., 1997; Jevtovic-Todorovic et al., 1998) and
voltage-gated (Takenoshita and Steinbach, 1991) ion chan-
nels is modulated by inhalational general anesthetics. How-
ever, whether these changes in membrane protein function
are attributable to direct effects of bound anesthetics or are
instead an indirect result of changes in the physical prop-
erties of the lipid component of the plasma membrane
(Cantor, 1997; Tu et al., 1998) remains to be determined.
A second obstacle to understanding mechanisms of an-
esthetic action has been the lack of methods that allow the
investigator to directly monitor binding of these relatively
weakly interacting ligands to proteins. However, techniques
have been introduced in recent years that are based upon
19F-NMR spectroscopy (Dubois and Evers, 1992; Dubois et
al., 1993), direct photoaffinity labeling (Eckenhoff and Shu-
man, 1993), and fluorescence quenching (Johansson et al.,
1995; Johansson, 1997), which allow the energetics of bind-
ing to be determined. The latter two techniques have the
added advantage of providing information about the loca-
tion of the bound anesthetic in the protein matrix. The
demonstration of a direct interaction between anesthetic and
protein is a crucial first step in understanding how these
compounds might alter protein function.
The generic structural features of volatile anesthetic bind-
ing sites on proteins are being explored by use of a model
system consisting of a four--helix bundle scaffold with a
hydrophobic core (Johansson et al., 1996, 1998a; Johans-
son, 1998). The core can be modified using standard syn-
thetic chemistry, allowing direct testing of the importance
of both cavity size and potential amino acid side-chain
electrostatic contributions to anesthetic binding. These syn-
thetic peptide bundles are proposed to serve as scaled-down
water-soluble models for the lipid-spanning domains of a
number of structurally defined membrane proteins (Rees et
al., 1989; von Heijne, 1994; Doyle et al., 1998). The ratio-
nale for this approach is supported by the evidence that the
transmembrane portions of ligand-gated ion channels such
as the GABAA receptor (Mihic et al., 1997) and the nicotinic
acetylcholine receptor from Torpedo nobiliana (Eckenhoff,
1996a) may directly interact with volatile anesthetics.
In this paper, the design, synthesis, and initial character-
ization of a four--helix bundle that contains a relatively
high-affinity binding site for halothane is reported. The
location of the bound anesthetic was determined using both
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fluorescence quenching measurements and direct photoaf-
finity labeling, followed by microsequencing. The fluores-
cence quenching experiments and the direct photoaffinity
labeling studies provide complementary information and
reveal that the anesthetic indeed binds in the designed cavity
in the hydrophobic core of the four--helix bundle. In
addition, the structural and dynamic properties of the four-
-helix bundle are examined using molecular dynamics
(MD) computer simulations.
MATERIALS AND METHODS
Materials
9-Fluorenylmethoxycarbonyl (Fmoc)-protected amino perfluorophenyl es-
ters were purchased from PerSeptive Biosystems (Framingham, MA), with
the exception of 9-fluorenylmethoxycarbonyl-L-Arg(2,2,5,7,8-pentameth-
ylchroman-6-sulfonyl)-pentafluorophenyl ester (Fmoc-L-Arg(Pmc)- Opfp),
which was obtained from Bachem (King of Prussia, PA). Halothane
(2-bromo-2-chloro-1,1,1-trifluoroethane) was from Halocarbon Laborato-
ries (Hackensack, NJ). The thymol preservative present in commercial
halothane was removed with an aluminum oxide column (Shibata et al.,
1991). [14C]Halothane ([1-14C]-2-bromo-2-chloro-1,1,1-trifluoroethane;
50 mCi/mmol) was purchased from DuPont NEN (Boston, MA). Guani-
dinium chloride (GndCl) (8.0 M) was obtained from Pierce (Rockford, IL).
Hexane and 2,2,2-trifluoroethanol (TFE) (NMR grade) were from Aldrich
Chemical Co (Milwaukee, WI). All other chemicals were of reagent grade
and were purchased from Sigma Chemical Co. (St. Louis, MO).
Peptide synthesis and preparation
Peptides were assembled on NovaSyn PR-500 resin (Novabiochem, La
Jolla, CA), using the Fmoc/tert-butyl (Fmoc/tBu) protection strategy on a
Milligen 9050 (Cambridge, MA) instrument (Robertson et al., 1994; Ra-
banal et al., 1996; Gibney et al., 1997a; Johansson et al., 1998a,b; Johan-
sson, 1998). Reversed-phase C18 high-performance liquid chromatography
(HPLC) with aqueous acetonitrile gradients containing 0.1% (v:v) triflu-
oroacetic acid was used to purify crude peptides to homogeneity. Peptide
identities were confirmed with laser desorption mass spectrometry. Solu-
tion molecular weights were determined with gel filtration on a Superdex
75 FPLC column (Pharmacia Biotechnology, Piscataway, NJ), using the
following molecular mass standards: aprotinin (6.5 kDa), cytochrome c
(12.4 kDa), chymotrypsinogen A (25.0 kDa), carbonic anhydrase (29.0
kDa), ovalbumin (43.0 kDa), and bovine serum albumin (67.0 kDa).
Circular dichroism spectroscopy
Spectra were recorded on a model 62 DS spectropolarimeter (Aviv, Lake-
wood, NJ), using 2-mm pathlength quartz cells. The cell holder was
temperature controlled at 25.0  0.1°C. The buffer was 10 mM potassium
phosphate at pH 7.0. The bandwidth was 1.00 nm, with a scan step of 0.5
nm and an average scan time of 3.0 s.
Denaturation studies
Denaturation of four--helix bundles was followed using circular dichro-
ism (CD) spectroscopy, monitoring the ellipticity at 222 nm (222), as
described (Johansson et al., 1998a). The measured 222 as a function of the
added denaturant concentration was fit to the equation of Mok et al. (1996)
describing the unfolding of a dimer (four--helix bundle) into two mono-
mers, using a nonlinear least-squares routine,
Fraction folded
 1 expGH2O m  denaturant	/R  T

 4  P1 8  P/expGH2O
m  denaturant)/R  T)) 1)1/2], (1)
where GH2O is the conformational stability of the protein, m is the slope
of the unfolding transition, [denaturant] is the molar concentration of
GndCl, R is the gas constant, T is the absolute temperature, and P is the
molar monomer concentration of the protein.
Steady-state fluorescence measurements
Binding of halothane to the current four--helix bundle designs was
determined by using steady-state intrinsic tryptophan fluorescence mea-
surements (Johansson et al., 1995, 1996, 1998a) on a K2 multifrequency
cross-correlation phase and modulation spectrofluorometer (ISS, Cham-
paign, IL). Tryptophan was excited at 280 nm (bandwidth 2 nm), and
emission spectra (bandwidth 8 nm) were recorded with peaks at 327 nm for
(DesAc-A2)2 (peptide lacking an N-terminus acetyl group) and 323 nm
for (DesAc-A2-L38M)2. A 305-nm emission cut-on filter was used to
minimize the transmission of scattered excitation light. The quartz cell had
a path length of 10 mm and a teflon stopper. The cell holder was thermo-
statically controlled at 25.0  0.1°C. The buffer used for the fluorescence
experimentation was 130 mM NaCl, 20 mM sodium phosphate (pH 7.0).
Protein concentrations were determined with a UV/Vis Spectrometer
Lambda 2 (Perkin-Elmer, Norwalk, CT), taking 280 for tryptophan 5700
M1 cm1 (Edelhoch, 1967). Halothane-equilibrated bundle proteins, in
gas-tight Hamilton syringes (Reno, NV), were diluted with predetermined
volumes of plain protein (not exposed to anesthetic, but otherwise treated
in the same manner) to achieve the final anesthetic concentrations indicated
in the figures.
As described previously (Johansson et al., 1995, 1996, 1998a), the
quenched fluorescence (Q) is a function of the maximum possible quench-
ing (Qmax) at an infinite halothane concentration ([Halothane]) and the
affinity of halothane for its binding site (Kd) in the vicinity of the trypto-
phan residues. From mass law considerations, it then follows that
Q Qmax  Halothane	/Kd Halothane	. (2)
Photoaffinity labeling and sequencing
Deoxygenated four--helix bundle solutions (7 M in 50 mM sodium
phosphate, pH 7.0) containing 0.2 mM [14C]halothane (50 mCi/mmol)
were exposed to 254-nm light (mercury pencil calibration lamp; Oriel,
Stratford, CT) for 60 s in 5-mm-path length quartz cuvettes at room
temperature, with constant stirring. Peptides were washed and concentrated
using 3-kDa molecular mass cutoff filters (Amicon, Beverly, MA) and then
sequenced directly on an Applied Biosystems (Foster City, CA) model
473A sequencer. Small-scale analytical runs (50 pmol) confirmed the
expected identity and release pattern for the first three residues. Radioac-
tivity release was then obtained using pre-HPLC samples from 2 nmol
peptide load.
Hydrogen exchange
Peptides (3–5 mg) were dissolved in 1 ml of 1 M guanidinium chloride and
50 mM sodium phosphate (pH 8.5), with 40 l 3HOH added (100 mCi/ml;
ICN, Costa Mesa, CA), and allowed to equilibrate overnight at 20°C to
permit complete exchange-in of tritium. The peptide solutions were then
Halothane Binding to a Four--Helix Bundle 983
Biophysical Journal 78(2) 982–993
passed through a PD-10 gel filtration column (Sigma Chemical Co.) to
remove free 3HOH and to switch to the exchange-out buffer, 50 mM
sodium phosphate (pH 7.0). The protein fraction was collected and imme-
diately placed in gas-tight Hamilton syringes prefilled with exchange-out
buffer, with or without 4 mM halothane. The syringe contents were mixed
with microstir bars, and 100-l aliquots were precipitated with 2 ml 20%
trichloroacetic acid (TCA) at regular intervals, immediately filtered
through Whatman (Hillsboro, OR) GF/F filters, and washed with 8 ml 2%
TCA. Filters were equilibrated with 10 ml fluor overnight and counted with
the use of liquid scintillation. Parallel aliquots allowed determination of
protein concentration, using UV/Vis absorption spectroscopy at 280 nm.
Protection factors for given hydrogens were determined from the ex-
change-out curves (Fig. 8). Assuming the horizontal equivalence of hydrogen
exchange (the nth hydrogen to exchange is the same with and without anes-
thetic), protection factor ratios were estimated by dividing the time required for
a given hydrogen to exchange under differing conditions (i.e., with and without
anesthetic) and were determined for the last hydrogens in common for the two
conditions. Protection factor ratios (Pfrs) were averaged, and G values (the
change in the free energy favoring the folded conformation) were determined,
using the relationship G  RTln(Pfr), where R is the gas constant and T
is the absolute temperature. Negative values reflect the stabilization of the
native folded conformation (slower exchange), and positive values indicate
destabilization (faster exchange).
Molecular dynamics simulations
The equilibrium structures of the solvated four--helix bundles (Ac-A2)2
and (Ac-A2-L38M)2 were obtained (Davies et al., 1999a) with a state-
of-the-art MD program (Martyna et al., 1996). Initial coordinates for the
Ac-A2 monomer were generated with InsightII software (Molecular Sim-
ulations, San Diego, CA), following the primary sequence, secondary structure
domains, and relative residue orientations reported (Johansson et al., 1998a).
Two such monomers were placed in an anti topology such that the residues,
which occupy the a and d heptad positions, formed the hydrophobic core. An
aqueous environment for the (Ac-A2)2 four--helix structure was created by
immersion in a box containing 6700 water molecules, ensuring that no
overlap existed between water molecules and peptide. The AMBER95 force
field and parameters (Weiner et al., 1984, 1986; Cornell et al., 1995) were used
to describe the peptide interactions, and the TIP3P potential (Jorgensen et al.,
1983) was used for the water molecules.
After local minimization of the four--helix bundle structure, MD
equilibration of the solvated peptide was performed: 300 ps at a constant
temperature of 25°C, with a constant simulation box volume, followed by
1 ns at a constant pressure of 1 atmosphere, at the same temperature. The
averaged structure for (Ac-A2)2 in water was calculated over the last 500
ps of the MD constant-pressure trajectory. Coordinates for the (Ac-A2-
L38M)2 structure were obtained by substituting the L38 residue with M38
in the averaged configuration of (Ac-A2)2, using InsightII. This (Ac-A2-
L38M)2 structure was similarly solvated in a water box and minimized,
before MD equilibration was carried out for 300 ps at a constant temper-
ature (25°C) and volume, followed by a 300-ps trajectory at a constant
pressure (1 atmosphere), at the same temperature. Averaged structures for
both four--helix bundles were obtained using the last 100 ps of the
constant-pressure MD trajectories.
A single halothane molecule was placed in the hydrophobic pocket of
the equilibrated (Ac-A2-L38M)2 structure. Initial coordinates for the
anesthetic were generated with InsightII software. After minimization, MD
equilibration was performed for 300 ps, as above.
Gas chromatography
Buffer concentrations of halothane were determined, using gas chromatog-
raphy, with an HP 6890 series instrument (Hewlett Packard, Wilmington,
DE), as described (Johansson et al., 1996).
Curve fitting and statistics
Best-fit curves were generated with the KaleidaGraph (Abelbeck Software,
Reading, PA, 1994) program. Data are expressed as means  SD or SEM.
RESULTS
Protein design
The overall four--helix bundle scaffold (Fig. 1) was de-
signed to be water soluble and to have a hydrophobic core
as described (Robertson et al., 1994; Rabanal et al., 1996;
Gibney et al., 1996, 1997a,b). The bundles examined in this
study were based on prior designs (Gibney et al., 1996,
1997a,b) and were constructed from two 62-residue di--
helical peptides (Fig. 1), each composed of two 27-residue
amphiphilic -helical segments and an eight-residue flexi-
ble glycine linker. The bundle designs have two tryptophan
residues (W15) at hydrophobic heptad a positions (Fig. 2).
The primary sequences of the two 62-residue di--helical
peptides that are the focus of the current study are presented
in Fig. 2 a. The peptides described are designated DesAc-
A2, which is a variant of the Ac-A2 peptide reported
previously (Johansson et al., 1998a) that lacks the N-termi-
nus acetyl group, and DesAc-A2-L38M, which has a me-
thionine in place of a leucine at position 38 (a heptad e
position). The N-termini acetyl groups were omitted to
allow peptide microsequencing. The solution NMR struc-
ture of the four--helix bundle that served as a starting point
for the current bundle designs (Gibney et al., 1997b) sug-
gests that the 38 heptad e position is part of the hydrophobic
core (Skalicky et al., 1999).
In an effort to further our understanding of the structural
make-up of volatile anesthetic binding sites in proteins, we
introduced a potential electrostatic interaction in the vicinity
of the designed hydrophobic core cavity (Johansson et al.,
FIGURE 1 Modeled structure of the synthetic four--helix bundles. The
cylinders represent the two 27-residue amphiphilic -helical portions of
each 62-residue di--helical peptide, joined by an eight-residue glycine
linker. Black and white halves of each cylinder represent hydrophilic and
hydrophobic residues, respectively. Di--helical peptides dimerize in water
to form four--helix bundles.
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1998a) by replacing a heptad e position leucine with a
methionine to form (DesAc-A2-L38M)2. Methionine was
selected because it is similar to leucine in terms of size (both
residues have side-chain volumes of 124 Å3; Richards,
1974), helix-forming propensity (O’Neil and DeGrado,
1990a), and hydrophobicity (Nozaki and Tanford, 1971;
Urry et al., 1992; Wimbley and White, 1996) but contains
the more polarizable sulfur atom, which potentially pro-
vides energetically more favorable interactions with a
bound hydrophobic ligand (Fersht and Dingwall, 1979;
Gellman, 1991). A tryptophan occupies a position at one
end of the putative cavity (W15; Fig. 2 a) to permit protein
concentration determination (Edelhoch, 1967) and to allow
monitoring of anesthetic binding (Johansson et al., 1995,
1996, 1998a; Johansson, 1997, 1998). In addition, the tryp-
tophan residue may provide a weak electrostatic contribu-
tion to the overall anesthetic binding energetics (Dougherty,
1996; Eckenhoff and Johansson, 1997).
-Helical content and conformational stabilities
of the four--helix bundles (DesAc-A2)2 and
(DesAc-A2-L38M)2
CD spectroscopy was used to measure the -helical content
of the four--helix bundles (DesAc-A2)2 and (DesAc-
A2-L38M)2 and to evaluate the effect of removing the
capping acetyl group from the N-terminus. Table 1 shows
that the []222 (in deg cm
2 dmol1) of (DesAc-A2)2 and
(DesAc-A2-L38M)2 is 22,000 and 21,600, respectively.
For comparison the []222 of the N-capped (Ac-A2)2
bundle is 23,000 deg cm2 dmol1. The measured []222
FIGURE 2 (a) Primary sequences of the
(DesAc-A2)2 and (DesAc-A2-L38M)2 di--he-
lical peptides, with hydrophobic heptad a and d
residues shown in bold. The C-termini have car-
boxyamide groups. The heptad repeat assign-
ments (abcdefg) used to design amphiphilic -he-
lices are shown above the initial amino acids of
each di--helical peptide. (b) End-on view of anti
four--helix bundle, showing the interaction of
the hydrophobic core residues at the heptad a and
d positions. The dashed lines indicate how suc-
cessive hydrophobic core layers are composed of
two a and two d residues. Modified from Betz et
al. (1997).
TABLE 1 Spectral and thermodynamic properties of the four--helix bundles (DesAc-A2)2, (DesAc-A2-L38M)2, and (A2)2
Four--Helix
Bundle
Solution
Molecular
Mass (kDa)
Fluorescence
Maximum
(nm)
GH2O
(kcal/mol)
m
(kcal/mol M)
[]222
(deg cm2 dmol1)
Halothane Kd
(M)
(DesAc-A2)2 13.2 327 11.5  0.3 1.8  0.1 22,000 690  60
(DesAc-A2-L38M)2 14.9 323 11.7  0.2 2.0  0.1 21,600 200  10
(A2)2 18.5 327 14.3  0.8 2.0  0.2 23,000 710  40
Data for (A2)2 are taken from Johansson et al. (1998a), except for the solution molecular mass, which was redetermined using a different column described
under Materials and Methods.
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values for (DesAc-A2)2 and (DesAc-A2-L38M)2 trans-
late into percentage -helical contents of 79.0% and 77.3%,
respectively, using a value of 32,000 deg cm2 dmol1 for
100% -helix (Lau et al., 1984). Removal of the N-termini
acetyl groups therefore results in a 4–5% decrease in -he-
lical content.
The conformational stabilities of the two four--helix
bundles (DesAc-A2)2 and (DesAc-A2-L38M)2 were de-
termined using chemical denaturation with GndCl. The el-
lipticity at 222 nm for the four--helix bundles was mea-
sured as a function of added denaturant, and the data were
fit using Eq. 1. Fig. 3 shows that both (DesAc-A2)2 and
(DesAc-A2-L38M)2 undergo full denaturation in the pres-
ence of GndCl. The calculated GH20 and m values for the
two four--helix bundles are given in Table 1. Removal of
the two N-termini acetyl groups leads to a 3 kcal/mol
destabilization of both four--helix bundles compared to the
parent bundle (Ac-A2)2, in line with the 1–2 kcal/mol
-helix stabilizing effect attributed to the presence of a
single N-capping group (Bryson et al., 1995).
Location of Met38
The solution NMR structure of the four--helix bundle
(Gibney et al., 1997b) that served as an initial model for the
current bundle designs revealed that the 38 heptad e position
residue (a tryptophan) is located in the hydrophobic core
(Skalicky et al., 1999). The fluorescence yields of the W15
residues in the two current bundles (DesAc-A2)2 and
(DesAc-A2-L38M)2 were compared to determine whether
the methionine at position 38 formed part of the hydropho-
bic core. Methionine will quench the tryptophan fluores-
cence (Ballew et al., 1996) if the sulfur atom is located
within 7 Å of the indole ring (Yuan et al., 1998). Fig. 4
shows that the W15 fluorescence yield of the (DesAc-A2-
L38M)2 bundle is 67–73% (n  2) of that displayed by the
(DesAc-A2)2 bundle, indicating that the methionine side
chain is located in the vicinity of W15.
Binding of the volatile anesthetic halothane to
the hydrophobic cores of the
four--helix bundles
The binding of halothane to the four--helix-bundle
(DesAc-A2-L38M)2 hydrophobic core was followed by
tryptophan fluorescence quenching (Johansson et al., 1995,
1996, 1998a), as shown in Fig. 5. Halothane causes a
concentration-dependent quenching of the intrinsic W15
fluorescence, without changing the emission maximum, in-
dicating that halothane binds in the vicinity of the indole
rings without altering the local dielectric environment. Fur-
thermore, the lack of a red shift in the tryptophan fluores-
cence emission maximum upon halothane binding suggests
that the anesthetic does not promote unfolding of the bun-
dle, which would lead to increased water exposure of the
indole rings. Fig. 6 a shows a plot of the bundle tryptophan
fluorescence as a function of the halothane concentration.
Fitting the data with Eq. 2 yields a Kd  0.20  0.01 mM
with a Qmax  0.98  0.01, indicating that the fluorescence
of both of the tryptophan residues in the bundle core is
quenched by bound anesthetic. For comparison, Fig. 6 b
shows the measured binding of halothane to the hydropho-
bic core of the bundle (DesAc-A2)2. The calculated bind-
ing parameters are Kd  0.69  0.06 mM and Qmax 
0.97  0.02, again implying that the fluorescence of both
tryptophan residues is quenched. The affinity of halothane
binding to the (DesAc-A2-L38M)2 is increased as com-
pared to the (DesAc-A2)2 bundle, by a factor of 3.5.
The importance of bundle tertiary structural interactions
for anesthetic binding is shown in Fig. 6 c, which demon-
strates the diminished quenching of W15 fluorescence in the
FIGURE 3 Four--helix bundle denaturation
curves as monitored by spectropolarimetry at 222 nm.
(a) (DesAc-A2)2. (b) (DesAc-A2-L38M)2. The
GH20 and m values calculated with Eq. 1 are given in
Table 1.
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(DesAc-A2-L38M)2 bundle by halothane after bundle dis-
sociation with TFE. TFE negates the hydrophobic interac-
tions that underlie four--helix bundle formation (Zhou et
al., 1992), while maintaining secondary structure (Jasanoff
and Fersht, 1994). The magnitude of fluorescence quench-
ing in 50% TFE is comparable to that measured when
halothane is added to free L-tryptophan in solution (Johans-
son et al., 1995, 1996, 1998a) and results from collisional
encounters between halothane and the dissociated di--
helical peptides.
Photoaffinity labeling and microsequencing of the
four--helix bundles
After exposure to 60 s of UV light, both peptides had
incorporated label at an approximate stoichiometry of 1:1
bundle. Exposing the (DesAc-A2-L38M)2 bundle to a de-
naturing GndCl concentration (2 M; Fig. 3) resulted in much
less label incorporation (0.07:1 bundle), compatible with
specific labeling of the native four--helix bundle structure.
Microsequencing revealed the expected initial five residues
FIGURE 4 Relative W15 fluorescence
yields of the four--helix bundles (DesAc-
A2)2 (a) and (DesAc-A2-L38M)2 (b). In
both cases, the peptide concentration was 4.8
M, as shown by the absorption spectra in c.
Excitation was at 280 nm, with emission
maxima at 327 and 323 nm for the (DesAc-
A2)2 and (DesAc-A2-L38M)2 bundles, re-
spectively.
FIGURE 5 Quenching of the (DesAc-A2-L38M)2
bundle (5 M) W15 fluorescence by halothane. Ex-
citation was at 280 nm, with the emission maximum at
323 nm. The concentrations of halothane were (a) 0,
(b) 72, (c) 142, (d) 250, and (e) 5000 M. The
fluorescence intensity has been normalized.
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from both bundles (LKKLR) with approximately the same
recovery from analytical samples. Larger samples (2 nmol)
were sequenced for 30 cycles (about half-way through the
peptide), and pre-HPLC recovery revealed the cpm shown
in Fig. 7 a. The (DesAc-A2)2 bundle released a small
number of counts along with the E6, A8, and F12 residues,
but the dominant release occurred coincidentally with the
W15 residue (Fig. 7 b). The W15:F12 release ratio was 8
for the (DesAc-A2)2 peptide. The (DesAc-A2-L38M)2
peptide also had minor release at the E6 and F12 positions,
but a much more pronounced release at the W15 cycle. In
the case of (DesAc-A2-L38M)2, the W15:F12 release ratio
was 50. For comparison, labeling of the (DesAc-A2-
L38M)2 bundle in the presence of a denaturing GndCl
concentration (2 M) resulted in the release of only one-sixth
of the counts associated with the folded bundle, and there
was no detectable release on the F12 cycle.
Effect of bound halothane on the dynamics of the
four--helix bundles
Fig. 8 shows that terminal hydrogen exchange rates for the
two four--helix bundles was comparable, consistent with
the similar stability estimates derived from the GndCl de-
naturation experiments (Table 1). Because these terminal
hydrogens exchange in 100 min (6000 s), and freely
exposed amide hydrogens exchange in 0.1 ms, protection
factors can be estimated to have values of 6  105. Assum-
ing that these slow hydrogens exchange only through global
unfolding events, the stability of the four--helix bundles is
estimated to be 8 kcal/mol, somewhat less than that mea-
sured by the GndCl denaturation experiments using CD
spectroscopy. This is not unexpected, because 1) hydrogen
exchange probes the stability of tertiary and quarternary
structure in this dimeric peptide, whereas the GndCl dena-
turation experiments as followed by CD spectroscopy probe
secondary structure, and it is not clear how cooperative the
unfolding event is in these peptides (m values in Table 1),
and 2) the slow hydrogens in these peptides may exchange
through pathways involving incomplete unfolding events.
More importantly, the folded conformation of both bun-
dles was stabilized in the presence of halothane. Thus halo-
thane stabilized the (DesAc-A2)2 and (DesAc-A2-
L38M)2 bundles by 0.7 and 0.9 kcal/mol, respectively,
consistent with the premise of preferential binding to the
folded dimeric bundle. The difference in halothane-induced
stabilization on the order of 0.2 kcal/mol implies a differ-
ence in Kd values for halothane binding for the two bundles
of 1.4, somewhat less than the 3.5-fold difference found
using fluorescence quenching to monitor anesthetic binding.
However, the overall agreement in both direction and mag-
nitude is reasonable when one considers the global versus
regional nature of the two approaches for determining an-
esthetic binding to the four--helix bundles.
Molecular dynamics simulations of the
four--helix bundles
Molecular dynamics (MD) simulations were carried out to
begin to understand how the position 38 residue (leucine
versus methionine) might play a role in anesthetic binding.
The predominant -helical nature of the peptide backbone is
maintained during the simulation for both solvated (Ac-
A2)2 and (Ac-A2-L38M)2 four--helix bundles, in agree-
ment with the experimental results. The individual helices
were observed to undergo bending and twisting during the
equilibration. The hydrophobic heptad a and d position
residues remain buried within the core of the four--helix
bundles, with the exception of the positively charged argi-
nine residues (R5 and R58) near both termini, in agreement
with the solution NMR structure of a closely related four-
-helix bundle (Skalicky et al., 1999).
The mean square displacements of the terminal methyl
carbon atoms in residue 38 with respect to the C atom were
monitored during the simulations. The side chain of M38 in
the (Ac-A2-L38M)2 four--helix bundle was observed to
be more mobile than the L38 side chain in (Ac-A2)2,
which is in good agreement with experimental data (Gell-
man, 1991).
Both (Ac-A2)2 and (Ac-A2-L38M)2 four--helix bun-
dles exhibit a hydrophobic pocket that can bind at least one
halothane molecule. A snapshot taken from the initial phase
of equilibration of the solvated (Ac-A2-L38M)2 bundle
with halothane is shown in Fig. 9. The distance between the
sulfur atom of M38 and the indole ring of W15 is such that
a halothane molecule can be accommodated. Therefore, it is
plausible that a single halothane molecule, which exhibits
end-on-end rotational and translational motions in the
FIGURE 6 Comparison of quenching profiles for the two four--helix
bundles (DesAc-A2-L38M)2 (a) and (DesAc-A2)2 (b) by added halo-
thane. The bundle protein concentration was 5 M. Data points are the
means of three to six experiments on separate samples; error bars represent
the SD. The lines through the data points have the form of Eq. 2. (c) Effect
of halothane on (DesAc-A2-L38M)2 W15 fluorescence in the presence of
50% (6.9 M) TFE.
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pocket, can satisfy the spatial requirements for fluorescence
quenching, especially since the side chains of M38 and W15
are also mobile.
DISCUSSION
The in vivo sites of volatile anesthetic action remain to be
determined, although membrane proteins in the central ner-
vous system are currently argued to be likely targets (Franks
and Lieb, 1994; Harris et al., 1995). The three-dimensional
structures of most ligand-gated ion channels, including
those thought to be important for anesthetic action, are not
yet clear. However, the transmembrane domains are be-
lieved to be composed of bundles of -helices, based upon
the few crystal structures available for other types of mem-
brane proteins (Rees et al., 1989; von Heijne, 1994; Doyle
et al., 1998). There is evidence that volatile general anes-
thetics interact directly with the transmembrane segments of
ligand-gated ion channels (Eckenhoff, 1996a; Mihic et al.,
1997). The utility of four--helix bundles as models for the
transmembrane domains is therefore being explored in an
effort to arrive at detailed structural and dynamic descrip-
tions of anesthetic-protein interactions (Johansson et al.,
1996, 1998a; Johansson, 1998), with the goal of understand-
ing mechanisms of anesthetic action.
The four--helix bundle reported on in the current study,
(DesAc-A2-L38M)2, is a variant of the bundle protein
(Ac-A2)2 that contains a designed cavity previously shown
to improve anesthetic binding affinity (Johansson et al.,
1998a). Replacing an -helical heptad e position leucine
with a methionine results in a further increase in the affinity
of anesthetic binding. The affinity with which (DesAc-A2-
L38M)2 binds halothane is comparable to the clinical EC50
of halothane of 250 M (Franks and Lieb, 1994), raising the
FIGURE 7 Disintegrations per cycle after micro-
sequencing of the (a) (DesAc-A2-L38M)2 and (b)
(DesAc-A2)2 four--helix bundle. Letters are stan-
dard amino acid abbreviations.
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possibility that similar affinity sites may also exist on in
vivo protein targets.
To date there have been few direct binding studies using
equilibrium approaches to define the energetics of haloge-
nated alkane interactions with proteins. Binding of halo-
thane to bovine serum albumin followed with 19F-NMR
spectroscopy (Dubois et al., 1993) and fluorescence quench-
ing (Johansson et al., 1995) resulted in Kd values of 1.3 
0.2 and 1.8 0.2 mM, respectively. The sites for anesthetic
binding on (DesAc-A2-L38M)2 therefore represent the
highest affinity binding sites for a volatile anesthetic de-
scribed so far by an equilibrium binding approach and
represent a severalfold increase in affinity compared to the
binding sites on bovine serum albumin.
The sites in (DesAc-A2-L38M)2 bind halothane with a
Kd  0.20  0.01 mM, as determined by the quenching of
W15 fluorescence. This corresponds to a 3.5-fold increase
in the affinity for the anesthetic compared to the parent
four--helix bundle with only the designed cavity (Ac-
A2)2 (Kd  0.71  0.04 mM) (Johansson et al., 1998a).
The effect of the leucine-for-methionine substitution on the
affinity of anesthetic binding might be explained by 1) a
further optimization of cavity size allowing for improved
van der Waals interactions, 2) a favorable electrostatic con-
tribution from the nucleophilic methionine sulfur atom, or
3) improved access to the cavity (on rate). A further opti-
mization of cavity size might follow from the greater flex-
ibility of the methionine side chain compared to leucine
(Bernstein et al., 1989; O’Neil and DeGrado, 1990b; Gell-
man, 1991). Leucine tends to adopt one of two low-energy
conformations in an -helical framework (McGregor et al.,
1987), while the methionine 3 torsion angle distributes
over the entire range of possibilities (Janin et al., 1978),
indicating an absence of a preferred orientation. This raises
the possibility that the methionine residue may interact
directly with the bound anesthetic. This interpretation is
supported by 1) the decreased W15 fluorescence yield of the
(DesAc-A2-L38M)2 bundle compared to the (DesAc-
A2)2 bundle, which suggests that the methionine side chain
is located within 7 Å of the indole ring (Yuan et al., 1998);
2) the photolabeling results shown in Fig. 7, which suggest
that halothane is better coordinated in the (DesAc-A2-
L38M)2 bundle compared to the (DesAc-A2)2 bundle,
based upon more dominant labeling of W15; and 3) the
initial molecular dynamics simulation results (Fig. 9). The
photoactivatable end of halothane at the C-Br bond, to-
gether with the probable heavy atom perturbation mecha-
nism of fluorescence quenching, indicates orientation of this
end of the anesthetic toward the indole ring. This would
suggest that the -CF3 end of halothane could be interacting
with the methionine sulfur atom. The sulfur atom on me-
thionine is considerably more polarizable (1.7-fold) than a
corresponding -CH2- group on leucine (Fersht and Ding-
wall, 1979). This implies that the predicted dispersion
forces that underlie volatile general anesthetic binding to
proteins (Eckenhoff and Johansson, 1997) will be enhanced,
FIGURE 8 Effect of halothane (4.0 mM) on terminal hydrogen exchange
rates in the (DesAc-A2-L38M)2 and (DesAc-A2)2 bundles. Open and
filled symbols represent, respectively, values measured in the absence and
presence of halothane. Squares and circles are data points for the (DesAc-
A2-L38M)2 and (DesAc-A2)2 bundles, respectively.
FIGURE 9 The equilibrium structure of the (Ac-A2-L38M)2 bundle
with complexed halothane from the constant pressure MD simulation,
showing (a) a side view and (b) a top view at the level of M38. The
backbones of the two di--helical peptides that dimerize to form a four-
-helix bundle are shown in light and dark green, W15 is in red, and M38
is in yellow, with the sulfur atom in orange. The halothane molecule is
shown, with carbon in gray, hydrogen in white, fluorine in brown, chlorine
in blue, and bromine in green.
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because the magnitude of these forces is proportional to the
polarizabilities of the interacting groups. Support for this
interpretation is provided by the finding (Johansson and
Zou, 1999) that halothane dissolves 5.2 times better in ethyl
methyl sulfide (a model for methionine) than in hexane (a
model for leucine). Alternatively, the flexibility of the me-
thionine side chain may translate into improved access to
the binding site in the hydrophobic core of the four--helix
bundle (DesAc-A2-L38M)2. A 3.5-fold increase in the on
rate would result in the determined improvement in affinity
of (DesAc-A2-L38M)2 for halothane compared to (DesAc-
A2)2. However, improved access to the hydrophobic core
would also be expected to be accompanied by a decrease in
the bundle stability, which is not supported by either the
GndCl denaturation experiments or the hydrogen exchange
results. An additional possibility is that two anesthetic mol-
ecules, rather than one, are accommodated in the hydropho-
bic core of the (DesAc-A2-L38M)2 bundle secondary to
allosteric modulation of the dimensions of the binding site
by the methionine substitution. In agreement with this are
the molecular dynamics results for the (Ac-A2-L38M)2
bundle, which suggest that the hydrophobic pocket is large
enough to accommodate two halothane molecules. Further
high-resolution structural studies using NMR spectroscopy
or x-ray crystallography will be required to definitively
address these alternative explanations.
The fluorescence quenching results indicate that halo-
thane binds to the (DesAc-A2-L38M)2 bundle in close
proximity to the W15 residues. This follows because heavy
atom perturbation, the presumed mode by which halothane
quenches tryptophan fluorescence, is a short-range phenom-
enon, occurring over distances of less than 3–5 Å (Tsao et
al., 1989; Basu et al., 1993). The results obtained using
direct photoaffinity labeling followed by microsequencing
of the bundle protein provide support for this view. Similar
complementary results have been reported for the model
mammalian protein bovine serum albumin, where fluores-
cence quenching suggested that the halothane bound in
close proximity to the two tryptophan residues W134 and
W212 (Johansson et al., 1995) and photoaffinity labeling
showed that these two residues were indeed preferentially
labeled after halothane photolysis (Eckenhoff, 1996b). This
indicates that there is good agreement between the two
methods for determining the general location of halothane-
binding sites within the protein matrix.
The hydrogen exchange results suggest that halothane
binding stabilizes the native folded conformations of the
four--helix bundles. This is in agreement with prior studies
on the (Ac-A2)2 four--helix bundle (Johansson, 1998)
and on bovine serum albumin (Eckenhoff, 1998; Johansson
et al., 1999) and adds further support for the hypothesis that
volatile general anesthetics may alter protein function by
perturbing the equilibrium between different protein con-
formations.
The molecular dynamics simulations of the solvated four-
-helix bundles (Ac-A2)2 and (Ac-A2-L38M)2 indicate
that both structures are stable and primarily -helical, in
agreement with the CD results. Localization of A8, F12, and
W15 within the hydrophobic core in the averaged structures
is in accord with the photolabeling results. Residue 38 is
observed to support part of the hydrophobic core near W15,
which is the proposed site for anesthetic binding (Fig. 9).
Examination of the initial results for halothane dynamics in
the hydrophobic pocket (Davies et al., 1999b) suggests that
it is plausible for a single halothane molecule to satisfy the
spatial proximity to W15 required for fluorescence quench-
ing. Halothane is also found to exhibit both rotational and
translational motions in the binding pocket (Davies et al.,
1999b), which, coupled with the dynamics of the W15 and
M38 side chains, allows for effective fluorescence quench-
ing by the bound anesthetic. Structural differences between
the (Ac-A2)2 and (Ac-A2-L38M)2 bundles complexed
with halothane cannot be inferred at this point but are
predicted to play a role in the enhanced binding specificity
displayed by the latter. Simulations addressing these issues
are currently being performed.
In summary, synthetic peptides are allowing predictions
to be made concerning the structural makeup of in vivo
general anesthetic binding sites and have enabled a direct
test of the hypothesis that the clinical EC50 for halothane
(250 M) might correspond to the Kd of a single protein
target. It should be noted, however, that a clinical EC50
value is unlikely to correspond to the Kd of a binding site on
a protein, because the relationship between the ligand con-
centration that produces a functional effect and the target
dissociation constant is often shifted (Eckenhoff and Johan-
sson, 1997). However, higher affinity sites are more likely
to be occupied by an anesthetic molecule than lower affinity
sites, at clinical concentrations. Taken together, the results
with these simple models suggest that volatile general an-
esthetics are likely to occupy preexisting appropriately sized
hydrophobic cavities on proteins and that the presence of
methionine and aromatic residues lining the cavity favors
anesthetic binding. The small size of these protein bundles
will permit the structural and dynamic consequences of
anesthetic binding to be probed through detailed biophysical
approaches and MD simulations. For example, one of the
consequences of a bound volatile general anesthetic that has
been explored recently is the effect on global protein sta-
bility as reported here and previously (Johansson, 1998;
Eckenhoff, 1998; Johansson et al., 1999). Thus stabilization
of the native, folded protein by a bound anesthetic molecule
may prevent the conformational changes required for pro-
tein function, perhaps representing a fundamental mecha-
nism of volatile anesthetic action.
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